Genprex, Inc. Operating Income Loss

• Genprex, Inc. showed an increase of +26.7% in Operating Income Loss from 2024 to 2025.
• This data is from Genprex, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Genprex, Inc.'s Operating Income Loss has declined by 275.5%.
• Historical annual values: Fiscal year 2025: -$15.52 million | Fiscal year 2024: -$21.17 million | Fiscal year 2023: -$31.06 million | Fiscal year 2022: -$23.83 million | Fiscal year 2021: -$20.67 million | Fiscal year 2020: -$17.96 million | Fiscal year 2019: -$10.68 million | Fiscal year 2018: -$12.36 million | Fiscal year 2017: -$3.31 million | Fiscal year 2016: -$4.13 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026